Get the Stockscreener App
144.36
0.99%
1.41
Illumina Inc Stock (ILMN) Latest News
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
This Illumina Insider Increased Their Holding In The Last Year - Yahoo Finance
Daiwa Securities Group Inc. Sells 8,783 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Citigroup Inc. Increases Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Life Science Tools Market Generated Opportunities, Future - openPR
Illumina, Inc. (ILMN): Constrained Spending in Pharmaceutical Industry Pressures Shares Despite Strong Niche Position - Yahoo Finance
Early access users rave about Illumina’s new MiSeq i100 Series - Illumina
Loomis Sayles & Co. L P Has $566.34 Million Stake in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
MYGN Stock Up on Integration of HRD Platform Into Illumina's TSO 500 v2 - Yahoo Finance
Swedbank AB Has $56.84 Million Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 10,455 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Stake Cut by Pathstone Holdings LLC - MarketBeat
Massachusetts Financial Services Co. MA Raises Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Purchases Shares of 5,441 Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Stocks With Rising Relative Strength: Illumina - MSN
Edgewood Management LLC Sells 19,221 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Jennison Associates LLC Acquires 89,663 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Metagenomics Market Is Booming Worldwide 2024-2031 | Bio-Rad - openPR
United States Non-Invasive Prenatal Testing Market Report 2025-2033: Illumina, Roche, and Natera, which have Established Themselves as Leaders through Robust Research and Development - Yahoo Finance
Bioinformatics Market Size, Trends, Growth, Opportunities - openPR
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Trailblazing study shows early CGP leads to better precision treatments - Illumina
Primecap Management Co. CA Buys 87,599 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Buys 114,466 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina gear up to expand TruSight Oncology portfolio - Medical Device Network
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Myriad Genetics Announces Incorporation of its Proprietary - GlobeNewswire
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2 - Yahoo Finance
(ILMN) Trading Report - Stock Traders Daily
Illumina's Moat in Sequencing Remains Narrow - Morningstar
Illumina To Present At Wolfe Research 2024 Healthcare Conference; Webcast At 9:20 AM ET - Nasdaq
ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio - Yahoo Finance
Gene Panel Market: Rapid Growth with Strong Future CAGR and Top - openPR
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Victory Capital Management Inc. - MarketBeat
Biological Multiplex Assays Market to Witness Significant - openPR
U.S. STOCKS Merck, Microstrategy, Illumina - XM
Illumina to unveil new tumor profiling assay at AMP - Investing.com
Illumina announces expansion of TruSight Oncology portfolio - Illumina
LMR Partners LLP Takes Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
RNA Sequencing Market Expected to Experience Positive Growth - openPR
NGS Based RNA Sequencing Market 2024 Analysis of Key Trends, - openPR
Digital Genome Market May See a Big Move | Illumina, GE Healthcare, Inscripta - openPR
How two systems integration scientists ensure a smooth workflow on MiSeq i100 - Illumina
Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now? - Yahoo Finance
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Mutual of America Capital Management LLC - MarketBeat
CIBC Asset Management Inc Sells 19,552 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
10 Best Immunotherapy Stocks to Buy Now - Insider Monkey
NGS & Microarray Training - Illumina
Illumina, Inc. (NASDAQ:ILMN) Shares Purchased by Impax Asset Management Group plc - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
North America Bioinformatics Market Statistical Forecast - openPR
ING Groep NV Raises Stake in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Plato Investment Management Ltd Raises Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Oppenheimer & Co. Inc. Sells 10,424 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
DNA Test Kits Market Future Business Opportunities 2024-2031 | - openPR
Instrument Services - Illumina
12,000 Shares in Illumina, Inc. (NASDAQ:ILMN) Purchased by Freemont Management S.A. - MarketBeat
10,563 Shares in Illumina, Inc. (NASDAQ:ILMN) Bought by Entropy Technologies LP - MarketBeat
Illumina's SWOT analysis: ngs leader faces competition, aims for growth - Investing.com
Biochips Market Is Booming Worldwide 2024-2031 | Illumina, - openPR
Illumina's SWOT analysis: ngs leader faces competition, aims for growth By Investing.com - Investing.com UK
Urban Illumina 2024 at MDI Gurgaon Illuminates Insights, Entertainment, and Engagement through Disguised Market Research - Passionate In Marketing
Single-cell RNA analysis finds possible genetic drivers of bone cancer - Illumina
Mengis Capital Management Inc. Purchases New Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Consumer Genomics Industry Next Big Thing | Major Giants- Veritas, Illumina, Xcode Life - openPR
0.41%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):